Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (271-280 of 527) with videos related to

Pageof 53
Sort By:
Journal of Personalized Medicine|July 2, 2021
PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in <sup>11</sup>C-Methionine PET and SurvivalTatjana Traub-Weidinger, Nina Poetsch, Adelheid Woehrer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 18, 2021
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatmentGerd Jomrich, Dagmar Kollmann, Dariga Ramazanova, et al.
European Journal of Neurology|June 2, 2026
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center StudyAnna Grisold, Angelika M Starzer, Sara Silvaieh, et al.
Anticancer Research|October 28, 2020
Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma SamplesMartin Filipits, Matthias Preusser, Johannes A Hainfellner, et al.
Neuro-Oncology|August 29, 2024
NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastasesEmilie Le Rhun, Lakshmi Nayak, Mary Jane Lim-Fat, et al.
Cellular and Molecular Neurobiology|April 3, 2014
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cellsGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
World Neurosurgery|July 31, 2020
Postoperative Magnetic Resonance Imaging After Surgery of Brain Metastases: Analysis of Extent of Resection and Potential Risk Factors for Incomplete ResectionBarbara Kiesel, Romana Prihoda, Martin Borkovec, et al.
Cancers|December 19, 2019
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with GliomaPegah Mir Seyed Nazari, Christine Marosi, Florian Moik, et al.
Neuro-Oncology|October 11, 2014
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkDamien C Weber, Yucai Wang, Robert Miller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 13, 2013
Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patientsAnna Sophie Berghoff, Manuel Magerle, Ayseguel Ilhan-Mutlu, et al.
Pageof 53

Showing results (271-280 of 527) with videos related to

Sort By:
Pageof 53
Journal of Personalized Medicine|July 2, 2021
PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in <sup>11</sup>C-Methionine PET and SurvivalTatjana Traub-Weidinger, Nina Poetsch, Adelheid Woehrer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 18, 2021
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatmentGerd Jomrich, Dagmar Kollmann, Dariga Ramazanova, et al.
European Journal of Neurology|June 2, 2026
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center StudyAnna Grisold, Angelika M Starzer, Sara Silvaieh, et al.
Anticancer Research|October 28, 2020
Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma SamplesMartin Filipits, Matthias Preusser, Johannes A Hainfellner, et al.
Neuro-Oncology|August 29, 2024
NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastasesEmilie Le Rhun, Lakshmi Nayak, Mary Jane Lim-Fat, et al.
Cellular and Molecular Neurobiology|April 3, 2014
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cellsGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
World Neurosurgery|July 31, 2020
Postoperative Magnetic Resonance Imaging After Surgery of Brain Metastases: Analysis of Extent of Resection and Potential Risk Factors for Incomplete ResectionBarbara Kiesel, Romana Prihoda, Martin Borkovec, et al.
Cancers|December 19, 2019
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with GliomaPegah Mir Seyed Nazari, Christine Marosi, Florian Moik, et al.
Neuro-Oncology|October 11, 2014
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkDamien C Weber, Yucai Wang, Robert Miller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 13, 2013
Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patientsAnna Sophie Berghoff, Manuel Magerle, Ayseguel Ilhan-Mutlu, et al.
Pageof 53